Evofem Biosciences, Inc.
EVFM
$0.0099
$0.00044.21%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -232.05% | 119.88% | -43.66% | -103.58% | 115.79% |
| Total Depreciation and Amortization | 221.43% | 350.85% | 1,368.18% | 729.73% | 112.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 119.29% | -376.10% | 217.65% | 101.43% | -171.39% |
| Change in Net Operating Assets | -43,850.00% | 95.25% | -157.74% | 201.94% | -100.10% |
| Cash from Operations | -155.83% | 355.28% | -1,316.47% | 80.58% | 23.63% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -307.14% | -- | -- | 100.00% |
| Total Debt Issued | 607.30% | -- | -100.00% | -100.00% | -20.28% |
| Total Debt Repaid | 1.98% | -- | -73.38% | 73.80% | -- |
| Issuance of Common Stock | -- | -- | 4,210.34% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 123.78% | -- | 627.35% | -53.32% | 91.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12,133.33% | 237.61% | -88.82% | 113.27% | 100.33% |